Global Clinical Trial Outsourcing Market Size Likely to Grow at a CAGR of 7.46% By 2033

Global Clinical Trial Outsourcing Market size was valued at USD 43,102.4 Million in 2024 and is expected to reach USD 91,210.1 Million by 2033, at a CAGR of 7.46% during the forecast period 2024 – 2033.

Clinical Trial Outsourcing Market: Overview

Clinical trial outsourcing is increasing worldwide due to the growing number of clinical trials. It is a very cost-effective method for conducting clinical trials. Clinical research organisations can provide a range of services, from key capabilities to product approval and commercial launches.

Various factors, such as accelerated adoption of clinical trial outsourcing, increasing investment in drugs in the pipeline, growing investment in pharmaceutical drug innovations, rapidly expanding pharmaceutical industry in emerging economies, and increasing prevalence of chronic diseases creating burgeoning demands for new drugs, are expected to drive the clinical trial outsourcing market during the forecast period.

However, the lack of coordination between clinical trial outsourcing companies, the shortage of skilled expertise in clinical trial organisations, the growing cost of clinical trial organisations, and lengthy drug approval processes are restraining the market’s growth.

Key players operating in the market are integrating various emerging technologies, such as artificial intelligence, blockchain, machine learning, predictive analytics, advanced drug testing kits, etc., in their clinical trials to foster the speed and accuracy of clinical trials.

Machine learning-based software is integrated into many clinical trials to analyse the vast clinical requirements and patterns. Artificial intelligence-based technologies are helping to foster speed and accuracy in clinical trials, thereby boosting the drug approval processes and creating lucrative market opportunities during the forecast period.

Growing collaborations between key players involved in the clinical trial outsourcing market and biopharmaceutical companies to develop advanced and customised clinical trial technologies and equipment are expected to create lucrative market opportunities during the forecast period. For instance, many biopharmaceutical companies are collaborating with many clinical trial organisations to conduct clinical trials on a mass scale.

The global Clinical Trial Outsourcing market is segmented by services, phase, study design, application, and end users. By Services, the Laboratory Services segment dominated the global clinical trial outsourcing market and is expected to remain dominant during the forecast period. Laboratory services are the most crucial step in drug development and drug approvals.

By region, North America dominated the global Clinical Trial Outsourcing market and is expected to keep its dominance during the forecast period owing to the increasing number of clinical trials in this region coupled with growing investment in research and development activities in pharmaceutical drug development.

Various factors, such as a well-established pharmaceutical industry, increasing emphasis on new drug development due to the growing prevalence of various chronic diseases, and increasing supportive policies, are mainly driving the market growth of this region during the forecast period. Key countries, such as the U.S., Canada, and Mexico, are expected to drive the market growth of this region during the forecast period.

Report Scope

CMI has comprehensively analyzed the Clinical Trial Outsourcing market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth market scenario. Segment-wise market size and market share during the forecast period have been duly addressed to portray the probable picture of this Global Clinical Trial Outsourcing industry.

The competitive landscape includes key innovators, after-market service providers, market giants, and niche players, who are studied and analyzed extensively with respect to their strengths, weaknesses, and value-adding prospects. In addition, this report covers key players’ profiles, market shares, mergers and acquisitions, consequent market fragmentation, and new trends and dynamics in partnerships.

List of the prominent players in the Clinical Trial Outsourcing Market:

• Albany Molecular Research
• EVOTEC
• Laboratory Corporation of America Holdings
• Genscript
• ICON plc
• IQVIA
• Thermo Fisher Scientific Inc.
• SGS Life Sciences
• Charles River Laboratories
• Parexel
• Syneos Health
• Medpace
• LabCorp
• KCR
• PRA Health Sciences
• WuXi AppTec
• Pharmaron
• Avance Clinical
• Pharmaron
• Others

The Clinical Trial Outsourcing Market is segmented as follows:

By Services

• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Study Design

• Interventional
• Observational
• Expanded Access

By Applications

• Cancer
• Cardiovascular Diseases
• Nervous System Diseases
• Infectious Diseases
• Musculoskeletal Disease
• Gastroenterology Diseases
• Others

By End-User

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America